Many pressing medical challenges -such as diagnosing disease, enhancing directed stem cell differentiation, and classifying cancers -have long been hindered by limitations in our ability to quantify proteins in single cells. Mass-spectrometry (MS) is poised to transcend these limitations by developing powerful methods to routinely quantify thousands of proteins and proteoforms across many thousands of single cells. We outline specific technological developments and ideas that can increase the sensitivity and throughput of single-cell MS by orders of magnitude and usher in this new age. These advances will transform medicine and ultimately contribute to understanding biological systems on an entirely new level.
More generally, trends within groups -within different cell types, for instance -may disappear or even reverse when these groups are combined, as with population-average measurements.
This phenomenon is known as Simpson's paradox 18 . We recently demonstrated 19 the confounding effects of Simpson's paradox in using mRNA levels as surrogates for protein levels with bulk data, Fig. 2a . Similarly, Simpson's paradox can confound the interpretation of population-average protein levels as illustrated in Fig. 2b . If we only consider the average levels of the i th and the j th proteins across cell types, the proteins seem positively correlated ( Fig. 2b ). However, paradoxically, within each cell type the abundances of the i th and the j th proteins can have an inverse relationship ( Fig. 2b) . Perfect measurements of cell types sorted based on a few markers cannot resolve such phenomena; the true relationship can be observed only by measuring proteins in single cells. mRNA measurements (a) For a particular gene, its protein levels across tissues can be poorly predicted by its mRNA levels, while the average protein levels can be well predicted by scaled mRNA levels 19 . Thus mRNAs levels are unreliable surrogates for relative protein levels, and we need direct measurements of proteins. (b) A related manifestation of Simpson's paradox indicates that the average levels of the i th and the j th proteins may appear positively correlated, even though they are inversely correlated within a cell-type. Averaging across cells, even cell types sorted based on markers, will obscure the the relationship between the i th and the j th proteins.
Single-cell proteomics opens exciting frontiers
Single-cell proteomics will allow us to perform causal protein inference and create unbiased models of direct and indirect protein interactions. These exciting prospects require estimating joint and conditional probability distributions of proteins across single cells, which in turn require many observations of individual proteins quantified across thousands of individual single cells. Such estimates have been obtained only for a few proteins, relying on antibodies or fluorescent proteins. Reliably-estimated joint distributions of proteoforms will enable modeling protein-protein dependencies with the empirical probabilities, without assuming a sigmoidal, linear, or any specific relationship. Such models can infer the dependence and its causality between any two measured proteoforms while controlling -without assumptions -for the influence of all other measured proteoforms. Yet, these models can control only for the measured proteins. Thus, the full power of such analysis, which can lead to causal inference, requires measuring all relevant proteoforms.
We believe that high-throughput single-cell proteomics can estimate the joint distributions among the relevant proteforms, and in the process catalyze a transition from the population-average measurements to casual inference, elucidating direct and indirect protein interactions and signaling mechanisms. Similarly, the joint distributions enable estimating the mutual information (MI) between proteins. The MI inequality states that the mutual information between a variable X, e.g., a kinase, and its causal variable, e.g., an upstream kinase, is always larger than the mutual information between X and another correlated but not causal variable. This allows us to determine which protein kinases are upstream and downstream in a signaling cascade, or another similar biological sequence of causal events. Such progress will produce models that can predict and design the outcomes of new treatments, e.g, rationally engineer directed differentiation of stem cells into cell types of interest. Realizing these promises requires increasing both the sensitivity and the throughput of of single-cell proteomics. We believe both factors can be increased by orders of magnitude based on the suggestions outlined below.
Transformative opportunities for realizing single-cell proteomics
In the foreseeable future, two types of technologies are likely to increase the number of proteins quantified per single cell: (i) antibody-based methods and (ii) MS-based methods. Antibodybased methods have a long track-record of success. For many years, the binding of antibodies to a few cellular proteins has been assayed by measuring fluorophores, transition metals and more recently DNA sequences conjugated to the antibodies. Such methods have measured up to a few dozen proteins per cell. Efforts are underway to increase this number while overcoming molecular crowding limitations and ensuring cellular permeability, antibody availability, binding specificity, epitope availability. In contrast to antibody-based methods, MS-based methods for quantifying proteins in single cells is in its infancy. Yet, initial attempts have already quantified hundreds of proteins per cell and thousands of proteins over many single cells 20 . Below we focus on MSbased methods as we believe they have the potential to afford unparalleled specificity, measurement accuracy, depth of proteome coverage and flexibility in experimental design.
So far, most single-cell MS studies have used either (i) MALDI-TOF 2 whose quantitative accuracy is undermined by variable and incomplete ionization, or (ii) quantitative electrospray ionization (ESI) methods. The first glimmers of the potential for ESI-MS to profile the proteomes of single cells began in the 1990s, with the targeted detection of a few highly abundant proteins at or near single-cell equivalent levels [21] [22] [23] . More recently, ESI-MS has been used in conjunction with other significant innovations to detect many more proteins in single human oocytes 24 or small samples from single embryonic frog cells (blastomeres) 25, 26 . Even with mammalian cells having diameter ∼ 15 µm, ESI-MS has made progress in quantifying increasing number of proteins in relatively small number of cells, reaching thousands of proteins in cell lysates corresponding to hundreds of cells 27 or even fewer cells 28 . Recently, we reported a method that allows quantifying over a thousand proteins across many single mouse stem cells 20 . We believe that the field is ready to take off from this launching point, and increase the number of accurately-quantified proteins and the number of single cells assayed by orders of magnitude.
The relatively high copy number of proteins per cell 29 
Sample preparation
Cell extraction and separation for single-cell proteomics can be similar to cell extraction for other analytical methods, i.e., single-cell RNA-seq, and such methods have been reviewed extensively 31 . Standard MS preparation methods for bulk samples use 10 − 100 µl volumes; reducing these volumes to a few nl or less will afford a substantial reduction in protein loss and reagents used, Fig. 3a . This protein loss is primarily due to surface adsorption, which bulk proteomics overcomes by operating near the protein or peptide solubility limit. To mimic that approach for single-cell proteomics, given the ∼ 500 pg of protein in a typical mammalian cell 29 , the reaction volume should be limited to nanoliters. Just recently, proteomics preparations have been scaled down to hundreds of nanoliters 28 while single-cell transcriptomics often uses lysis volumes that are 100fold smaller, on the order of just a few nanoliters. 13 . Protein losses can be further reduced by passivating the surfaces interfacing with the samples. Taken together, the above approaches can decrease protein losses and thus increase the efficiency of protein delivery to the MS instrument by orders of magnitude, Fig. 3a . Furthermore, automated precision liquid handling will play a large role in single-cell proteomics, making sample preparation robust, high-throughput, and costeffective, Fig. 3d .
Peptide separation
Modern MS methods sample only a fraction of each elution peak, which corresponds to 1% or less of the ions for each peptide that the instrument could sample (Fig. 3b ). This small fraction is sufficient for the identification of peptides in bulk samples and maximizes peptide identification per unit time. Single-cell proteomics, however, can benefit from delivering the maximum number of ions from each peptide to the MS detectors. Two simple strategies can maximize the number of ions delivered: (i) improved peptide separation with tighter, and therefore taller, peaks, so that the number of ions sampled per unit time is increased; (ii) sampling a greater fraction of the elution peaks. The first strategy is technically demanding while the second one comes at the expense of reduced throughput per unit time. Such limitations can be partially compensated for by (i) improving the separation, i.e., using specialized liquid chromatography (LC) columns 27 or capillary electrophoresis 25, 35 (which is particularly promising for top-down MS), or by (ii) making all measurements targeted to proteins of interest, which involves programming the MS instrument to sequence specific peptides. These strategies, alone or combined, have the potential to increase 10 − 100 fold the number of ions delivered to the instrument, and thus increase the sensitivity of single-cell proteomics by 10 − 100 fold, Fig. 3b ,c.
Parallel ion accumulation
Data Dependent Acquisition (DDA) with current MS hardware operates by selecting specific ions and fragmenting them for identification and quantification. The ions are serially accumulated and serially analyzed. This strategy is efficient when accumulation times are short. In bulk samples, ions are abundant enough so that sampling them for a very short time results in reliable identification and quantification. However, single-cell MS ideally should sample a large fraction of the ions, which requires accumulating ions over longer periods of time. If ion accumulation is serial, longer accumulation increases sensitivity but at the expense of fewer quantified peptides per unit time. This trade-off can be resolved by accumulating ions in parallel, so that we gain sensitivity without losing throughput. The most obvious way to accomplish parallel accumulation and parallel injection is by using Data Independent Acquisition (DIA). Since DIA does not allow direct quantification from the reporter ions of isobaric tags, we can adapt it to use the complement ions that remain bound to peptide fragments. Parallel accumulation with serial injection can be accomplished by using additional accumulation traps built into the MS instrument ( Fig. 3e ).
Alternatively, parallel accumulation and serial injection can be achieved by trapped ion mobility spectrometry 36 . For long accumulation times, and thus sensitive MS, the increase in throughput by parallel accumulation is proportional to the number of ions accumulated in parallel, and we expect to gain 2 − 10 fold, Fig. 3e .
Higher multiplexing for increased throughput
Achieving high chromatographic resolution and quantifying 1000s of proteins requires an hour of LC-MS/MS time or more. Thus, to quantify the proteomes of thousands of single cells within hours, we need to quantify many cells per LC-MS/MS run. Such multiplexing can be achieved by isobaric chemical barcoding 37, 38 . These barcodes are chemically identical, but distinguishable by MS due to their different isotopic compositions. While there are a number of commerciallyavailable barcode sets, the largest such set only allows the simultaneous analysis of eleven different samples. However, larger sets of barcodes can be synthesized and indeed many colleagues are actively working on making multiplex tags that would allow 30 − 100 individual cells to be measured in parallel (Fig. 3f ). In creating new barcodes for single-cell proteomics, there is an opportunity to solve an outstanding problem with the technology, coisolation: quantitative fragments from the currently-available barcodes are not peptide specific, allowing the signal to be polluted by fragments from different peptide species 39 . The barcode labeling chemistry would have to be changed such that the barcode to peptide bond is much stronger or the barcodes require less energy for fragmentation, allowing the quantification to be based on peptide-specific complement ions.
Protein identification and data analysis
While the analysis of single-cell MS data can use tools developed for bulk MS [40] [41] [42] , it raises specific challenges and opportunities. One specific challenge is peptide sequencing. At very low abundance, many peptides may not produce enough fragment ions to support confident identification. One solution may be to include a carrier cells together with single cells, each of which is labeled with a unique tandem-mass-tag 20 . With this strategy, the fragment ions supporting peptide identification are derived from peptides pooled across all samples, including the carrier channel 20 .
Combining this strategy with increases in the number of distinct tandem-mass-tags will further facilitate peptide identification and decrease the need for carrier cells. Another approach is to use additional peptide characteristics, such as retention time or empirical mass spectra. These approaches can exploit the fact that single-cell proteomics data will contain multiple similar runs that can be used, for example, for making spectral libraries. As previously discussed, quantifying 1000s of single cells in a reasonable time frame requires barcoding, which will benefit from new computational approaches to accurately merge quantitative data sets acquired separately. If single-cell proteomes are quantified by shotgun MS, the proteins quantified in different runs will overlap partially, with some proteins quantified across all MS runs, while others only in a subset of the runs. This partial overlap will result in missing data, i.e., the levels of some proteins will not be quantified in some single cells. Such missing data are pervasive with respect to single-cell RNA-seq 30 and must be handled carefully in single-cell proteomics to avoid artifacts.
The number of confidently identified peptides or proteins has served as a popular MS benchmark.
Indeed, this number is informative for the depth of discovery when only a few bulk samples are analyzed by MS and only proteins quantified across all samples can be meaningfully analyzed.
However, when the proteomes of many hundreds of cells are analyzed, all proteins quantified across a large enough number of cells can be analyzed. Consider, for example, a shotgun MS study profiling 10, 000 single cells and quantifying a pair of proteins, A and B, across only 10 % of the cells. Despite the low probability of quantifying A and B, we can still analyze the 1, 000 cells in which these proteins are quantified and compute a meaningful correlations between A and B. Thus, the most relevant benchmark for the depth of single-cell proteomics is the subset of proteins quantified across large enough number of cells to allow for biological inferences for these proteins. The number of proteins quantified per run and across every single cell is a technological benchmark with limited practical significance. As we increase the number of quantified single-cell proteomes, the number of proteins quantified in every cell can only decrease, while the number of proteins quantified across many cells will increase, and so will the coverage of the proteome that can be analyzed.
Focusing exclusively on maximizing proteome coverage per cell can substantially undermine the throughput (number of analyzed cells) and the accuracy of quantification. This is because longer nLC gradients will generally provide more time to sample more ions and thus contribute to larger number of identified peptides per run. However, because the run takes longer, fewer samples can be analyzed per instrument per unit time and thus fewer cells quantified. Furthermore, longer gradients generally will result in broader elution peaks and thus fewer ions sampled per unit injection time. As discussed above, sampling fewer ions will result in larger relative sampling error, equal to 1/ √ n, where n is the number of sampled ions. Algorithms for matching spectra between runs are an excellent way to increase depth of coverage. However, such approaches do not assign confidence to the new spectral assignments. We are excited for efforts to incorporate both retention time and spectral information into a rigorous statistical framework to increase the number of confidently-identified and accurately-quantified peptides. This potential for small sampling error and for highly controlled, direct ratiometric measurements (no need for amplification, surrogates or reporters) supports the imminent possibility of deep and accurate quantification of single-cell proteomes. This prospect, the opportunities for increased multiplexing and the new analytical methods afforded by these data can revolutionize biology and medicine.
Outlook and community engagement
In this perspective, we highlighted the most exciting and approachable opportunities towards realizing high-throughput and cost-effective single-cell proteomics. We aimed to make our perspective accessible for the broadest audience possible, because we hope that it will stimulate a communitywide discussion via meetings and workshops dedicated to single-cell proteomics 43 . We hope to catalyze interdisciplinary collaborations that focus technological developments towards answering the most promising biological questions and solving biomedical problems. Single-cell proteomics is an imminent opportunity to revolutionize biology and medicine. Realizing this opportunity requires a unified effort of colleagues with diverse expertise, including instrument engineers, separation scientists, mass spectrometry experts, statisticians, and biologists.
